This activity will provide learners with the latest developments in translational medicine for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

The leading cause of non-relapse post- allogeneic hematopoietic stem cell transplant mortality is GvHD manifesting as immunobiological warfare waged by the donor cells against multiple organ systems in the recipient

Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents

This three part series is comprised of case-based enduring activities will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.